Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
GFAP Antibody, Novus Biologicals™

Goat Polyclonal Antibody has been used in 6 publications
Supplier: Novus Biologicals NB10053809
Description
GFAP Polyclonal specifically detects GFAP in Human, Mouse, Rat samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Peptide ELISA, Immunohistochemistry Free-Floating, Immunohistochemistry Whole-Mount.Specifications
GFAP | |
Polyclonal | |
Unconjugated | |
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA with 0.02% Sodium Azide | |
FLJ45472, GFAP astrocytes, glial fibrillary acidic protein | |
Goat | |
50 kDa | |
0.1 mg | |
Astrocyte Markers, Cancer, Cell Biology, Cellular Markers, Chaperone Mediated Autophagy (CMA), Inflammation, Neurodegeneration, Neuroscience, Signal Transduction, Stem Cell Markers | |
2670 | |
Mouse, Rat | |
IgG |
Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), ELISA, Immunohistochemistry (Free Floating) | |
0.5 mg/mL | |
Western Blot 0.001 - 0.01 ug/mL, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Peptide ELISA Detection limit 1:128000, Immunohistochemistry Free-Floating, Immunohistochemistry | |
NP_002046.1 | |
GFAP | |
This GFAP Antibody was developed against a peptide with sequence C-DGEVIKESKQEHKD corresponding to C-Terminus according to NP_002046.1. | |
Affinity Purified | |
RUO | |
Primary | |
GFAP is thought to help to maintain astrocyte mechanical strength, as well as the shape of cells but its exact function remains poorly understood, despite the number of studies using it as a cell marker. | |
Store at -20C. Avoid freeze-thaw cycles. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction